bezafibrate has been researched along with Acute Coronary Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, HR; Huang, WY; Huang, XS; Li, XP; Zhao, SP | 1 |
| Amit, U; Fisman, EZ; Goldenberg, I; Haitovich, A; Klempfner, R; Matetzky, S; Medvedofsky, D; Shemesh, J; Tenenbaum, A | 1 |
| Amit, U; Fisman, EZ; Goldenberg, I; Klempfner, R; Matetzky, S; Shemesh, J; Tenenbaum, A | 1 |
| Gong, HR; Huang, WY; Li, XP; Zhao, SP | 1 |
2 trial(s) available for bezafibrate and Acute Coronary Syndrome
| Article | Year |
|---|---|
The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Apolipoprotein A-V; Apolipoproteins A; Atorvastatin; Bezafibrate; Cholesterol, HDL; Drug Synergism; Drug Therapy, Combination; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hypolipidemic Agents; Male; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2013 |
[The lipid-regulating effect and safety of combined statin and bezafibrate therapy in acute coronary syndrome patients complicating with dyslipidemia].
Topics: Acute Coronary Syndrome; Aged; Anticholesteremic Agents; Atorvastatin; Bezafibrate; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lipoproteins; Male; Middle Aged; Pyrroles; Treatment Outcome | 2013 |
2 other study(ies) available for bezafibrate and Acute Coronary Syndrome
| Article | Year |
|---|---|
Bezafibrate treatment is associated with a reduced rate of re-hospitalization in smokers after acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Aged; Bezafibrate; Chi-Square Distribution; Drug Therapy, Combination; Female; Health Care Surveys; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Israel; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Patient Readmission; Registries; Risk Factors; Sex Factors; Smoking; Time Factors; Treatment Outcome | 2014 |
Comparison of statin alone versus bezafibrate and statin combination in patients with diabetes mellitus and acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Bezafibrate; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Israel; Male; Middle Aged; Morbidity; Prospective Studies; Survival Rate; Treatment Outcome | 2014 |